News

1. September 2015

Probiodrug Licenses the TBA 2.1 Transgenic Alzheimer's Disease Mouse Model to QPS Austria Neuropharmacology

27. August 2015

Probiodrug reports financial results for H1 2015

24. August 2015

Probiodrug to present at the International Conference on Brain Disorders and Therapeutics in London, UK

20. August 2015

Probiodrug AG to Publish First Half 2015 Results on 27 August, 2015 

10. August 2015

Probiodrug to present at Canaccord Genuity 35th Annual Growth Conference in Boston

30. Juli 2015

Univations und bmp vereinbaren Zusammenarbeit - Startups profitieren von Know-how und Zugang zu Kapital

14. Juli 2015

Probiodrug Funds Brigham and Women's Hospital Research into pyroglutamate-Abeta for the Treatment of Alzheimer's Disease

1. Juli 2015

Mandat zum Management der IBG-Fonds in Sachsen-Anhalt geht an die bmp Beteiligungsmanagement AG

29. Mai 2015

Probiodrug to present at the Jefferies Healthcare Conference and BIO International Convention

29. Mai 2015

NOXXON stellt erste Ergebnisse aus klinischer Studie mit NOX-H94 (Lexaptepid Pegol) in ESA-hyporesponsiven Dialysepatienten auf der ERA-EDTA Konferenz vor

Seiten